Leading Pharma Companies Cut Costs Of Remdesivir Injections

Leading pharmaceutical companies, including Cadila Healthcare, Dr. Reddy's Laboratories, and Cipla, have cut the cost of Remdesivir injection to ensure a wider availability of the COVID-19 drug. According to the NPPA, all the pharma companies have priced their Remsdesivir injections (100 mg/vial) in the range of Rs 2,500 to Rs 4,000. Notably, several states across the country have reported a shortage of the antiviral injection.